Immunotherapy using autologous monocyte-derived dendritic cells pulsed with leukemic cell lysates for acute myeloid leukemia relapse after autologous peripheral blood stem cell transplantation.
about
Cellular immunotherapy as a beacon of hope for hematological malignanciesThe characterization and role of leukemia cell-derived dendritic cells in immunotherapy for leukemic diseasesRecent advance in antigen-specific immunotherapy for acute myeloid leukemiaInduction of complete and molecular remissions in acute myeloid leukemia by Wilms' tumor 1 antigen-targeted dendritic cell vaccinationEffects of TLR agonists on maturation and function of 3-day dendritic cells from AML patients in complete remission.The role of antigen cross-presentation from leukemia blasts on immunity to the leukemia-associated antigen PR1.Current progress in the development of a cell-based vaccine for the immunotherapy of acute myeloid leukemia.Biological response modifiers as adjuncts to stem cell transplantation.Dendritic cell vaccines for leukemia patients.Dendritic cell vaccination.Dendritic cell-based immunotherapy for myeloid leukemias.Combination of intensive chemotherapy and anticancer vaccines in the treatment of human malignancies: the hematological experienceRecent advances in antigen-loaded dendritic cell-based strategies for treatment of minimal residual disease in acute myeloid leukemia.Vaccines as consolidation therapy for myeloid leukemia.Clinical evaluation of cellular immunotherapy in acute myeloid leukaemia.Current strategies in immunotherapy for acute myeloid leukemia.DC-based immunotherapy for hematological malignancies.Spontaneous remission of acute myeloid leukemia.Update on antigen-specific immunotherapy of acute myeloid leukemia.Nonleukemic myeloid dendritic cells obtained from autologous stem cell products elicit antileukemia responses in patients with acute myeloid leukemia.Pulsing with blast cell lysate or blast-derived total RNA reverses the dendritic cell-mediated cytotoxic activity of cytokine-induced killer cells against allogeneic acute myelogenous leukemia cells.Chronic myeloid leukemia lysate-loaded dendritic cells induce T-cell responses towards leukemia progenitor cells.Large-scale generation of autologous dendritic cells for immunotherapy in patients with acute myeloid leukemia.Induction of multiple myeloma-specific cytotoxic T lymphocyte stimulation by dendritic cell pulsing with purified and optimized myeloma cell lysates.Generation of lymphocytes potentiated against leukemic lymphoblasts by stimulation using leukemic cell lysate-pulsed dendritic cells in patients with acute lymphoblastic leukemia and measurement of in vitro anti-leukemic cytotoxicity.Down-regulation of cellular vascular endothelial growth factor levels induces differentiation of leukemic cells to functional leukemic-dendritic cells in acute myeloid leukemia.
P2860
Q26784288-7E2B9008-2FF8-4779-8BDC-F68C2B0F155CQ26852652-52F6AD81-2118-4882-8AD5-CA97F6C4208EQ27005765-80A1D9C3-C8D6-46BA-AAC4-ADD641BBF992Q34068404-46F5EC3F-CDE2-4323-A820-38AC1C1FFFCDQ35240847-00D6B0A5-99DA-4962-83BF-3202738D52ECQ35888562-7D26CF10-CC17-40C2-91EA-14BEFE6B17FEQ36445541-C3AD3B87-03F0-438E-AA2B-4EBD09B07DAEQ36446933-6864A2FA-14CF-4009-98BF-3D671AC2AAF1Q36752018-833D2364-DBEA-4EE0-80A9-A553DBA555E4Q36899104-269D7D57-CE8F-46D2-AE2E-3EE699C5023FQ37420778-39FD3203-33B2-44D8-BC8C-27339831F880Q37772085-F2668FDA-E0F1-4433-B9A5-73435CAD2826Q37773237-CE6CD79E-C295-4CB5-B2B5-7FBF31A680F6Q37842342-7926EB91-528A-4982-8A39-F414593311E8Q37868974-7AEAA9C1-A4AB-40F3-BD98-F375ADC5D2B8Q38068967-A36635B6-2970-4905-891C-72AB66050F23Q38174828-3FC54CC2-D943-4D2E-A592-0A0AFCE5CCABQ38256921-B673A116-4FC0-43CD-9EA4-9ABD9677EEA8Q38432103-5DB1AB7E-5443-4DF1-97A9-5778D5952406Q39596000-F6D6B048-37AB-45DD-9C16-2C84B1E570B4Q41844970-5B7F262A-4B11-4E0A-81AC-724AFF5F6ACFQ44607712-E1A96294-AF10-43A6-9F9A-94601FBB2778Q45789544-E5A646AA-E72A-4483-A42F-7730E29EE076Q46965111-EA618006-6CE2-4BBC-88BB-92C029E9751FQ53378105-5EEA2F90-CEB8-4C28-9C8E-96F6D64634A3Q53585655-07A4C1E0-429E-4124-8D68-6A5A7A02B376
P2860
Immunotherapy using autologous monocyte-derived dendritic cells pulsed with leukemic cell lysates for acute myeloid leukemia relapse after autologous peripheral blood stem cell transplantation.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Immunotherapy using autologous ...... ood stem cell transplantation.
@en
Immunotherapy using autologous ...... ood stem cell transplantation.
@nl
type
label
Immunotherapy using autologous ...... ood stem cell transplantation.
@en
Immunotherapy using autologous ...... ood stem cell transplantation.
@nl
prefLabel
Immunotherapy using autologous ...... ood stem cell transplantation.
@en
Immunotherapy using autologous ...... ood stem cell transplantation.
@nl
P2093
P356
P1476
Immunotherapy using autologous ...... ood stem cell transplantation.
@en
P2093
Bo-Hwa Choi
Hyeoung-Joon Kim
Ik-Joo Chung
Il-Kwon Lee
Je-Jung Lee
Jong-Hee Nam
Kyeong-Soo Park
Myong-Suk Park
Tai-Ju Hwang
P356
10.1002/JCA.10080
P577
2004-01-01T00:00:00Z